Signaling Pathways
-
A2249 T0901317Target: Liver X receptors (LXRs)Summary: Liver X receptor agonist,potent and selective
-
A1947 MEK162 (ARRY-162, ARRY-438162)Target: MEKSummary: MEK1/2 inhibitor,potent and selective
-
A1605 Dynasore4 CitationTarget: GTPasesSummary: Dynamin and GTPase inhibitor
-
A1655 GW25801 CitationTarget: CSF-1RSummary: CFMS kinase/CSF-1R inhibitor,selective and ATP-competitive
-
A1709 GW9508Target: Free Fatty Acid ReceptorsSummary: FFA1/GPR40 agonist,potent and selective
-
A1986 Nu 6027Target: Cyclin-Dependent Kinases|ATM/ATRSummary: ATR/CDK inhibitor, potent and selective
-
A2477 Tyrphostin AG 12961 CitationTarget: PDGFRSummary: PDGFR inhibitor,selective and ATP-competitive
-
A1174 AMG-517Target: TRP ChannelSummary: TRPV1 antagonist,potent and highly selective
-
A2173 SC 1441 CitationTarget: GlycoproteinsSummary: Gp130 inhibitor
-
A1769 KU-00606481 CitationTarget: PI3K|DNA-PKSummary: Dual DNA-PK/PI3-K inhibitor, ATP-competitive